Moreover, the inhibition of Mst1 improved liver function, reversed steatosis, reduced OxS and inflammation and ameliorated NAFLD, with a concomitant restoration of mitophagy [146]. Here, MST1 is linked to metabolic dysfunction-associated steatotic liver disease.